A Study to Evaluate the Safety and Pharmacokinetics ABBV-399 in Japanese Participants With Solid Tumors
Clinical trial NCT03311477 · COMPLETED
Trial details
- NCT number
- NCT03311477
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-06
- Primary completion
- 2019-03-04
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.